Last Price
0.996
Today's Change
+0.031 (3.21%)
Day's Change
0.92 - 1.04
Trading Volume
1,354,699
Market Cap
174 Million
Shares Outstanding
175 Million
Avg Volume
16,713,995
Avg Price (50 Days)
1.48
Avg Price (200 Days)
1.40
PE Ratio
2.85
EPS
0.35
Earnings Announcement
27-May-2024
Previous Close
0.96
Open
0.92
Day's Range
0.92 - 1.0425
Year Range
0.256 - 21.09
Trading Volume
1,348,888
1 Day Change
3.26%
5 Day Change
1.63%
1 Month Change
-39.27%
3 Month Change
116.52%
6 Month Change
24.52%
Ytd Change
-91.04%
1 Year Change
-90.99%
3 Year Change
-89.98%
5 Year Change
-89.98%
10 Year Change
-89.98%
Max Change
-89.98%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.